A PGA response was achieved by 155 ( 471 % ) of 329 patients in the tofacitinib 5 mg group , 225 ( 682 % ) of 330 in the tofacitinib 10 mg group , 222 ( 663 % ) of 335 in the etanercept group , and 16 ( 150 % ) of 107 in the placebo group .